Novotech has the capability and experience to deliver global projects for Biotechs Our Locations Australia High quality research, facilities and equipment Fast set-up and approval times Sponsor can claim R&D cash refund Click for more Europe Europe has a thriving biotech sector and with European based CRO, EastHORN joining Novotech our presence give us improved access to this client base. Click for more Greater China Very large, homogenous population Strong focus of NMPA (previously CFDA) on shortening regulatory timelines Largest clinical trial hub in Asia, with over 17,000 active investigators Click for more India Large treatment-naïve population High disease population load The clinical activity grew by over 40% in 2018 on the back of regulatory pathway improvements About 1,800 investigators have participated on a minimum of 5 studies Click for more Malaysia Multiethnic Asian population Streamlined regulatory system and Strong govt. support Quick start-up timelines Low patient costs and IRB fees Click for more New Zealand High-quality research, facilities and equipment Fast set-up and approval times Sponsor can claim R&D cash refund Click for more Philippines Large treatment-naïve population Low costs Overall good level of English Click for more Singapore Multiethnic Asian population Regional clinical research hub Efficient regulatory process and good infrastructure Click for more South Africa Diverse Patient Population Efficient Regulatory Environment Cost-Effectiveness Click for more South Korea Homogenous and concentrated population High quality medical services and excellent infrastructure The most active Asian country in clinical research after China, with over 400 sites opened by biopharmas companies in 2018 Click for more Thailand Large homogenous population High prevalence of communicable diseases Efficient regulatory system Low operational cost Click for more United States Following the acquisition and integration of a long standing full-service CRO partner, Novotech now provides services across the United States Click for more Regions where we operate Australia High quality research, facilities and equipment Fast set-up and approval times Sponsor can claim R&D cash refund Click for more Europe Europe has a thriving biotech sector.Europe is an attractive clinical development region due to the commercial size of the end market, and availability of large patient populations (particularly in central and Eastern Europe).Europe has been a leader in the regulation of biosimilars, and so many of these trials occur in Europe. Click for more Greater China Very large, homogenous population Strong focus of NMPA (previously CFDA) on shortening regulatory timelines Largest clinical trial hub in Asia, with over 17,000 active investigators Click for more India Large treatment-naïve population High disease population load The clinical activity grew by over 40% in 2018 on the back of regulatory pathway improvements About 1,800 investigators have participated on a minimum of 5 studies Click for more Malaysia Multiethnic Asian population Streamlined regulatory system and Strong govt. support Quick start-up timelines Low patient costs and IRB fees Click for more New Zealand High-quality research, facilities and equipment Fast set-up and approval times Sponsor can claim R&D cash refund Click for more Philippines Large treatment-naïve population Low costs Overall good level of English Click for more Singapore Multiethnic Asian population Regional clinical research hub Efficient regulatory process and good infrastructure Click for more South Africa Diverse Patient PopulationEfficient Regulatory EnvironmentCost-Effectiveness Click for more South Korea Homogenous and concentrated population High quality medical services and excellent infrastructure The most active Asian country in clinical research after China, with over 400 sites opened by biopharmas companies in 2018 Click for more Thailand Large homogenous population High prevalence of communicable diseases Efficient regulatory system Low operational cost Click for more United States of America Following the acquisition and integration of a long standing full-service CRO partner, Novotech now provides services across the United States" Click for more
